5-Amino-1MQ is a synthetic small-molecule inhibitor of nicotinamide N-methyltransferase studied for metabolic regulation and muscle physiology. While roden
Read more 5-Amino-1MQ: Preclinical Evidence, Translational Hurdles, and Research Gaps
5-Amino-1MQ is a synthetic small-molecule inhibitor of nicotinamide N-methyltransferase studied for metabolic regulation and muscle physiology. While roden
Read more 5-Amino-1MQ: Preclinical Evidence, Translational Hurdles, and Research Gaps
A scientific analysis of BPC-157 evaluating its cytoprotective mechanisms, soft-tissue repair capabilities in preclinical models, and current human clinica
Read more BPC-157 Research Peptide: Mechanisms, Preclinical Evidence, and Clinical Translation
PE-22-28 is a synthetic, shortened derivative of spadin that selectively inhibits TREK-1 potassium channels, showing rapid-onset neurogenic and antidepress
Read more PE-22-28 Research Peptide: Mechanism, TREK-1 Blockade, and Preclinical Evidence